Abstract
The effect of the plasma oestradiol concentration on climacteric symptoms, gonadotrophin release, and bone resorption was studied in three groups of postmenopausal women given 0.025 mg, 0.05 mg, or 0.1 mg transdermal oestradiol daily. There was a dose related reduction in symptoms, plasma follicle stimulating hormone concentration, and urinary calcium and hydroxyproline excretion. The relation of the response to plasma oestradiol values was similar for each variable with an initial large reduction and little change in response to increases in the plasma oestradiol concentration above 150 pmol/l (41 pg/ml). Hormone replacement therapy producing an effect equivalent to higher oestradiol concentrations is likely to increase the risk of side effects without conferring any additional benefit.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Geola F. L., Frumar A. M., Tataryn I. V., Lu K. H., Hershman J. M., Eggena P., Sambhi M. P., Judd H. L. Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab. 1980 Sep;51(3):620–625. doi: 10.1210/jcem-51-3-620. [DOI] [PubMed] [Google Scholar]
- Jones M. M., Pearlman B., Marshall D. H., Crilly R. G., Nordin B. E. Dose-dependent response of FSH, flushes and urinary calcium to oestrogen. Maturitas. 1982 Dec;4(4):285–290. doi: 10.1016/0378-5122(82)90060-3. [DOI] [PubMed] [Google Scholar]
- Laufer L. R., DeFazio J. L., Lu J. K., Meldrum D. R., Eggena P., Sambhi M. P., Hershman J. M., Judd H. L. Estrogen replacement therapy by transdermal estradiol administration. Am J Obstet Gynecol. 1983 Jul 1;146(5):533–540. doi: 10.1016/0002-9378(83)90796-2. [DOI] [PubMed] [Google Scholar]
- Mack T. M., Pike M. C., Henderson B. E., Pfeffer R. I., Gerkins V. R., Arthur M., Brown S. E. Estrogens and endometrial cancer in a retirement community. N Engl J Med. 1976 Jun 3;294(23):1262–1267. doi: 10.1056/NEJM197606032942304. [DOI] [PubMed] [Google Scholar]
- Selby P. L., Peacock M., Barkworth S. A., Brown W. B., Taylor G. A. Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones. Clin Sci (Lond) 1985 Sep;69(3):265–271. doi: 10.1042/cs0690265. [DOI] [PubMed] [Google Scholar]
- Tjellesen L., Christiansen C., Hummer L., Larsen N. E. Unchanged biochemical indices of bone turnover despite fluctuations in 1,25-dihydroxyvitamin D during the menstrual cycle. Acta Endocrinol (Copenh) 1983 Mar;102(3):476–480. doi: 10.1530/acta.0.1020476. [DOI] [PubMed] [Google Scholar]
- Towobola O. A., Crilly R. C., Oakey R. E. Oestrone sulphate in plasma from postmenopausal women and the effects of oestrogen and androgen therapy. Clin Endocrinol (Oxf) 1980 Nov;13(5):461–471. doi: 10.1111/j.1365-2265.1980.tb03412.x. [DOI] [PubMed] [Google Scholar]